NQMC Update Service: November 25, 2013 ▲ British Medical Association

NQMC Update Service: November 25, 2013

NQMC Update Service: November 25, 2013

Agency for Healthcare Research and Quality (AHRQ) sent this bulletin at 11/25/2013 12:00 PM EST

November 25, 2013

New This Week

Measure Summaries British Medical Association Hypothyroidism: the contractor establishes and maintains a register of patients with hypothyroidism who are currently treated with levothyroxine. This updates a previously published measure summary. Hypothyroidism: the percentage of patients with hypothyroidism on the register with thyroid function tests recorded in the preceding 12 months. This updates a previously published measure summary. Peripheral arterial disease: the contractor establishes and maintains a register of patients with peripheral arterial disease. Peripheral arterial disease: the percentage of patients with peripheral arterial disease in whom the last blood pressure reading (measured in the preceding 12 months) is 150/90 mmHg or less. Peripheral arterial disease: the percentage of patients with peripheral arterial disease in whom the last measured total cholesterol (measured in the preceding 12 months) is 5 mmol/l or less. Peripheral arterial disease: the percentage of patients with peripheral arterial disease with a record in the preceding 12 months that aspirin or an alternative anti-platelet is being taken. Stroke and transient ischaemic attack (TIA): the contractor establishes and maintains a register of patients with stroke or TIA. This updates a previously published measure summary. Stroke and transient ischaemic attack (TIA): the percentage of patients with a history of stroke or TIA in whom the last blood pressure reading (measured in the preceding 12 months) is 150/90 mmHg or less. This updates a previously published measure summary. Stroke and transient ischaemic attack (TIA): the percentage of patients with a stroke or TIA (diagnosed on or after 1 April 2008) who have a record of a referral for further investigation between 3 months before or 1 month after the date of the latest recorded stroke or TIA. Stroke and transient ischaemic attack (TIA): the percentage of patients with a stroke shown to be non-haemorrhagic or a history of TIA who have a record in the preceding 12 months that an anti-platelet agent or an anti-coagulant is being taken. This updates a previously published measure summary. Stroke and transient ischaemic attack (TIA): the percentage of patients with stroke or TIA who have a record of total cholesterol in the preceding 12 months. This updates a previously published measure summary. Stroke and transient ischaemic attack (TIA): the percentage of patients with stroke or TIA who have had influenza immunisation in the preceding 1 September to 31 March. This updates a previously published measure summary. Stroke and transient ischaemic attack (TIA): the percentage of patients with stroke shown to be non-haemorrhagic or a history of TIA whose last measured total cholesterol (measured in the preceding 12 months) is 5 mmol/l or less. This updates a previously published measure summary.